Editorial: The role of platinum-based antitumor prodrugs in medicinal inorganic chemistry

被引：1
|
作者：
Margiotta, Nicola [1 ]
Ravera, Mauro [2 ]
Erxleben, Andrea [3 ]
机构：
[1] Univ Bari Aldo Moro, Dipartimento Chim, Bari, Italy
[2] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnolog, Alessandria, Italy
[3] Univ Galway, Sch Biol & Chem Sci, Galway, Ireland
来源：
FRONTIERS IN CHEMISTRY | 2023年 / 11卷
关键词：
cisplatin; oxaliplatin; carboplatin; prodrugs; medicinal inorganic chemistry;
D O I：
10.3389/fchem.2023.1180682
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
    Su, Shihao
    Chen, Yutong
    Zhang, Pengfei
    Ma, Ruijuan
    Zhang, Wei
    Liu, Jianing
    Li, Tao
    Niu, Hanjing
    Cao, Yi
    Hu, Bin
    Gao, Jinhua
    Sun, Hua
    Fang, Dong
    Wang, Jiajia
    Wang, Peng George
    Xie, Songqiang
    Wang, Chaojie
    Ma, Jing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 243
  • [2] Current status of platinum-based antitumor drugs
    Wong, E
    Giandomenico, CM
    CHEMICAL REVIEWS, 1999, 99 (09) : 2451 - 2466
  • [3] A platinum-based fluorescent "turn on" sensor to decipher the reduction of platinum(iv) prodrugs
    Yao, Houzong
    Zhu, Guangyu
    DALTON TRANSACTIONS, 2022, 51 (14) : 5394 - 5398
  • [4] Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours
    Fu, Qunfeng
    Zhang, Shuren
    Shen, Siyong
    Gu, Zhi
    Chen, Junyi
    Song, Dongfan
    Sun, Pengwei
    Wang, Chunhong
    Guo, Zhibin
    Xiao, Yunlong
    Gao, Yi Qin
    Guo, Zijian
    Liu, Zhibo
    NATURE BIOMEDICAL ENGINEERING, 2024, 8 (11): : 1425 - 1435
  • [5] Synergistic interaction between platinum-based antitumor agents and demethylcantharidin
    To, KKW
    Ho, YP
    Au-Yeung, SCF
    CANCER LETTERS, 2005, 223 (02) : 227 - 237
  • [6] Platinum-Based Antitumor Drugs and Their Liposomal Formulations in Clinical Trials
    D. A. Arantseva
    E. L. Vodovozova
    Russian Journal of Bioorganic Chemistry, 2018, 44 : 619 - 630
  • [7] Platinum-Based Antitumor Drugs and Their Liposomal Formulations in Clinical Trials
    Arantseva, D. A.
    Vodovozova, E. L.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2018, 44 (06) : 619 - 630
  • [8] Role of transporters in the distribution of platinum-based drugs
    Harrach, Saliha
    Ciarimboli, Giuliano
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [9] The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
    Zhou, Jiabei
    Kang, Yu
    Chen, Lu
    Wang, Hua
    Liu, Junqing
    Zeng, Su
    Yu, Lushan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] INTERACTION OF PLATINUM-BASED CYTOSTATICS AND PLATINUM NANOPARTICLES WITH METALLOTHIONEIN - POTENCIAL SOURCE OF THE ANTITUMOR DRUG RESISTENCE
    Zelnickova, Jaroslava
    Nejdl, Lukas
    Richtera, Lukas
    Kopel, Pavel
    Adam, Vojtech
    9TH INTERNATIONAL CONFERENCE ON NANOMATERIALS - RESEARCH & APPLICATION (NANOCON 2017), 2018, : 505 - 510
12345